19-Nov-2013 - University of Oxford

MRC Technology and Oxford University Collaborate to Develop Novel Pain Therapeutics for Migraine

MRC Technology, a technology transfer organisation, announced it is collaborating with Dr Zameel Cader at Oxford University’s Nuffield Department of Clinical Neurosciences, to screen selective and potent potassium channel activators to develop novel therapeutic interventions in migraine. Drawing on MRC Technology’s commercialisation expertise in drug discovery, the project focusses on bringing to clinic more effective pain treatments arising from the work of Dr Cader’s group in identifying KCNK18, the first gene underlying typical migraine.

KCNK18 encodes a tandem-pore background potassium channel, TRESK, which is linked to causing migraines and controls the sensitivity of pain nerves in the brain. If TRESK is faulty or inactive, the body’s threshold to pain can be significantly lowered. Migraine is the most common neurological disorder, with prevalence estimated at 18.2% in females and 6.5% in males, and is characterised by a severe, recurring headache, often accompanied by nausea, vomiting and increased sensitivity to light and sound.

Dr Justin Bryans at MRC Technology, said: “We are delighted to be working with Dr Cader and his team who have made such a significant discovery in the underlying causes of migraine. We are hopeful that our collaboration will lead to treatments that could not only prevent migraines, but could potentially result in a more general pain therapy with even wider impact."

“Migraine is a major cause of disability worldwide and it has been estimated to be the most costly neurological disorder in Europe,” commented Dr Cader. “We have made a major step forward in our understanding of why people suffer with migraine and with MRC Technology’s wealth of drug discovery experience, we look forward to working with them to bring novel treatments to market.”

Facts, background information, dossiers
  • migraine
  • University of Oxford
  • neurological disorders
More about University of Oxford
  • News

    Shaping the social networks of neurons

    The three proteins Teneurin, Latrophilin and FLRT hold together and bring neighboring neurons into close contact, enabling the formation of synapses and the exchange of information between the cells. In the early phase of brain development, however, the interaction of the same proteins lead ... more

    Tracking the HI virus

    An international team of researchers led by Dr Cyril Favard and Dr Delphine Muriaux from the Montpellier Infectious Disease Research Institute in collaboration with Prof. Dr Christian Eggeling from the Friedrich Schiller University Jena, the Leibniz Institute of Photonic Technology (Leibniz ... more

    Researchers use AI to establish molecular tumor classification and prognosis in patients with colorectal cancer

    Treating physicians need information about the molecular subtype of the tumor if they are to provide targeted therapy for colorectal carcinoma. A research team from University Hospital Zurich and the University of Oxford have now developed a method to predict the molecular classification of ... more

  • Videos

    Using VR to untangle genes

    Researchers from Oxford have been using VR to look at interactive models of genes. The simulations use data combined from genome sequencing, data on the interactions of DNA and microscopy data. It lets you see which parts of the genome sit interact with each other in physical space. regions ... more